Market Research Reports

All Reports Home

Categories

Countries

Pharmaceuticals Reports

Anxiety Disorders and Depression Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Antidepressant Drugs, Therapy and Devices, Others), By Indication (Obsessive-Compulsive Disorder, Major Depressive Disorder, Phobia, Others), By Region, By Competition, 2020-2030F

Increasing prevalence of anxiety disorders and depression is expected to drive the Global Anxiety Disorders and Depression Treatment Market growth in the Read More

Pharmacy Benefit Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service (Specialty Pharmacy, Drug Formulatory Management, Benefit Plan Design and Consultation, Other Services), By Business Model (Government Health Programs, Employer-Sponsored Programs, Health Insurance Management), End-user (Pharmacy Benefit Management Organization, Mail Order Pharmacies, Retail Pharmacies, Other End-Users), By Region, By Competition, 2020-2030F

Rising prevalence of various chronic diseases among the global population is expected to drive the Global Pharmacy Benefit Management Market growth in the Read More

India Cancer Therapeutics Market Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, and Others), By Application (Blood Cancer, Lung Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer, Glioblastoma, Malignant Meningioma, Mesothelioma, Melanoma, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising cancer incidence and expanding healthcare infrastructure are factors driving the India Cancer Therapeutics Market in the forecast period 2026-2030. Read More

India Erythromycin Market By Composition (Erythromycin Estolate v/s Erythromycin Stearate), By Application (Respiratory Tract Infections, Eye Infections, Ear Infections, Skin and Soft Tissue Infection, Gastro-intestinal Infections and Others), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Gel, Tablet, Capsule, Injection, Ointment, Ear and Eye Drops), By Distribution Channel (Online v/s Offline), By Route of Administration (Oral, Topical, Intravenous, Otic and Ophthalmic), By End User (Adult v/s Paediatric), By Region, Competition, Forecast & Opportunities, 2021-2031F

Growing prevalence of bacterial infections is expected to drive the India Erythromycin Market in the forecast period 2027-2031Read More

India Cefoperazone Market By Composition (Single, Combinational), By Route of Administration (Intramuscular v/s Intravenous), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By Application (Bacterial Infections, Respiratory Infections, Skin Infections, Urinary Infections, Others), By End User (Adult v/s Paediatric), By Region, Competition, Forecast & Opportunities, 2020-2030F

Growing prevalence of bacterial infections is expected to drive the India Cefoperazone Market in the forecast period 2026-2030Read More

India Gabapentin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Others), By Strength (100 mg, 200 mg, 300 mg, 400 mg, Others), By Distribution Channel (Online v/s Offline), By Application (Epilepsy, Neuropathic Pain, Restless Legs Syndrome (RLS), Seizures, Others), By End User (Adult v/s Paediatric), By Region, Competition, Forecast & Opportunities, 2021-2031F

Growing epilepsy and restless legs syndrome is expected to drive the India Gabapentin Market in the forecast period 2027-2031Read More

India Doxycycline Market By Product Type (Doxycycline HCL, Doxycycline Hyclate, Doxycycline Calcium, Doxycycline Monohydrate), By Form (Tablet, Capsule, Injection, Solution, Syrup, Others), By Application (Intestinal Infections, Respiratory Tract Infections, Skin Infections, Genital Infections, Urinary Tract Infections, Others), By Route of Administration (Oral, Intravenous, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By End User (Adult v/s Pediatric), By Region, Competition, Forecast & Opportunities, 2021-2031F

Growing prevalence of bacterial infections is expected to drive the India Doxycycline Market in the forecast period 2027-2031Read More

India Diclofenac Sodium Market By Product Type (Prescription v/s OTC), By Form (Tablet, Injection, Gel, Others), By Application (Osteoarthritis, Ankylosing Spondylitis, Dysmenorrhea, Rheumatoid arthritis, Migraine, Pain and Others), By Route of Administration (Oral, Intravenous, Topical, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By End User (Adult v/s Paediatric), By Region, Competition, Forecast & Opportunities, 2021-2031F

Growing cases of arthritis is expected to drive the growth of India diclofenac sodium market during the forecast period, 2027-2031Read More

Vietnam Over The Counter (OTC) Drugs Market, By Product Type (Cough, Cold, and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Minerals and Supplements(VMS), Weight Loss/Dietary Products, Ophthalmic Products, Sleeping Aids, and Other), By Formulation (Tablets, Liquids, Ointments, and Sprays), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, and Other), By Region, Competition Forecast & Opportunities, 2019-2029F

Growing demand for generic drugs is driving the growth of Vietnam Over the counter (OTC) drugs Market, in the forecast period, 2025-2029.Read More

India Gentamycin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Eye Drops, Tablet, Capsule, Syrup, Injection, Cream, Gel, Ointment, Others), By Route of Administration (Ophthalmic, Intravenous, Topical, Oral, Others), By Distribution Channel (Online v/s Offline), By Application (Bacterial Infection, Urinary Tract Infection, Sepsis, Meningitis, Skin or Soft Tissue Infection, Upper Respiratory Tract Infection, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F

Growing prevalence of bacterial infections is expected to drive the India Gentamycin Market in the forecast period 2027-2031Read More

India Cefixime Market By Route of Administration (Oral v/s Intravenous), By Dose (100 mg, 200 mg, 500 mg, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Powder, Injection, Others), By Distribution Channel (Online v/s Offline), By Application (Urinary tract infections, Otitis media, Pharyngitis and tonsillitis, Others), By End User (Adult v/s Children), By Region, Competition, Forecast & Opportunities, 2020-2030F

Increase in bacterial infections is expected to drive the India Cefixime Market in the forecast period, 2026-2030Read More

India Clindamycin Phosphate Market By Product Type (Prescription v/s OTC), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Gel, Topical Solution, Foam, Injection, Others), By Gender (Men v/s Women), By Distribution Channel (Online v/s Offline), By Application (Acne Vulgaris, Genito-Urinary Infections, Pseudomembranous Colitis, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F

Growing prevalence of skin infections is expected to drive the growth of India clindamycin phosphate market in the forecast period, 2027-2031Read More

Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Synthesis (Synthetic, Biotech, Monoclonal Antibodies, Recombinant Proteins, Vaccines, Hormones, Cytokines, Therapeutic Enzymes, Blood Factors), By Type of Manufacture (Captive APIs, Merchant APIs, Biotech Merchant APIs, Synthetic Merchant APIs), By Type (Generic APIs, Innovative APIs), By Application (Cardiovascular Diseases, Oncology, CNS and Neurology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Others), By Type of Drugs (Prescription, OTC), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising Healthcare Demand and Disease Prevalence and Government Initiatives and Policy Support are factors driving the Saudi Arabia Active Pharmaceutical Read More

Cosmeceuticals Market – Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Type (Skin Care, Hair Care, Oral Care & Others), By Material (Natural and Multifunctional/Synthetic), By Distribution Channel (Supermarket/Hypermarkets, Online Retail Stores, Pharmacy & Drug Stores, Others), By Ingredients (Antioxidants, Retinoid, Botanicals, Peptides & Proteins, Exfoliants and Others), By Region & Competition, 2020-2030F

Growing preference towards the natural/organic products along with rising disposable income is expected to drive the growth of global cosmeceuticals market Read More

India Ceftriaxone Market By Dose (100 mg, 200 mg, 250 mg, 500 mg and Others), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Intramuscular Injection, Intravenous Injection, Infusion, Others), By Distribution Channel (Online v/s Offline), By Application (Endocarditis, Meningitis, Pneumonia, Bone and Joint Infections, Intra-Abdominal Infections, Skin Infections, Urinary Tract Infections, Gonorrhoea, Others), By End User (Adult v/s Paediatric), By Region, Competition, Forecast & Opportunities, 2020-2030F

Growing prevalence of bacterial infections is expected to drive the India Ceftriaxone Market in the forecast period 2026-2030Read More

India Ciprofloxacin Market By Composition (Single v/s Combinational), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Powder, Suspension, Capsule, Tablet, Eye Drops, Ear Drop, Injection, Others), By Route of Administration (Oral, Ophthalmic, Otic, Intravenous, Others), By Distribution Channel (Online v/s Offline), By Application (Urinary Tract Infections, Lower Respiratory Infections, Nosocomial Pneumonia, Skin structure Infections, Bone and Joint infections, Intra-abdominal Infections, Acute Sinusitis, Conjunctivitis, Acute Otitis Externa, Others), By End User (Adult v/s Pediatric), By Region, Competition, Forecast & Opportunities, 2021-2031F

Increase in bacterial infections is expected to drive the India Ciprofloxacin Market in the forecast period, 2027-2031Read More

India Amoxicillin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Suspension), By Route of Administration (Oral v/s Intravenous), By Distribution Channel (Online v/s Offline), By Application (Respiratory Tract Infections, Skin Infections, UTI, Kidney Infections, Ear & Nose Infections, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Growing prevalence of respiratory diseases is expected to drive the India Amoxicillin Market in the forecast period 2026-2030Read More

Kenya Pharmaceutical Market By Drug Type (Generic Drugs, Branded Drugs), By Product Type (Prescription Drugs, Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast & Opportunities, 2020-2030F

Growing Population and Urbanization and Evolving Disease Profiles are factors driving the Kenya Pharmaceutical market in the forecast period 2026-2030.Read More

UAE Eye Drops Market By Type (Prescription, Over The Counter), By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others), By Disease Indication (Dry Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders, Others), By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy), By End User (Hospitals & Clinics, Homecare, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Increasing Prevalence of Eye Conditions and Growing Urbanization and Changing Lifestyles are expected to drive the demand of UAE Eye Drops Market in the forecast Read More

Herceptin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Biologic, Biosimilar), By Application (Breast Cancer, Stomach/Gastric Cancer, Others), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Others), By Region and Competition, 2020-2030F

Increasing prevalence of HER2-positive breast and gastric cancers, and rising adoption of targeted monoclonal antibody therapies are the factors driving the Read More

Prev    Page 17 of 30 Next